CTRI/2019/10/021812已完成未知
A randomized double blind placebo controlled parallel clinical study to evaluate the efficacy and safety of PARTY ZESTAHO liquid Curcumin for the prevention of hangover due to alcohol intoxication - ICBio-CR-ZNPL-0906-97
Zystus Nutraceuticals Pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1 Healthy male
- •2 Age 25-45 years have the willingness to
- •undergo alcohol drinking
- •3 Michigan Alcoholism Screening Test more than
- •2 to 5 (Attachment no.1)
- •4 Willing to provide written informed consent
- •for participation in the study and adhere to
- •the protocol requirements
排除标准
- •1 A medical history of significant hypersensitivity or allergic reaction to turmeric or related products
- •2 Volunteers have history of alcohol toxicity like liver cirrhosis neurological disease peptic disease diabetes drug abuse
- •3 Volunteers have undergone any concomitant medications like antibiotics, anticoagulants, tricyclic antidepressant, cardiovascular medication, sedative, hypnotics. Prior to 14 days
- •4 History of bile duct obstruction or Cysts of the common bile duct
- •5 If they have hypersensitivity for alcohol ingestion
- •6 If they have habit of smoking or tobacco chewing
研究者
相似试验
招募中
Unknown
Study to assess the effect of investigational product on gut health in overweight and obese adultsCTRI/2023/05/052961Vedic Lifesciences Pvt. Ltd
招募中
1 期
Randomized double-blind placebo controlled parallel-group phase 1-2 proof-of-concept clinical trial of the herbal preparation Sri Weera Badhra Dhamma Prathishakthi Jeewa Panaya© for patients with asymptomatic or with mild to moderate COVID-19.COVID-19, SARS-COV-2 infectionSLCTR/2021/001Ministry of Production, Supply and Regulation of Pharmaceuticals
已完成
不适用
A clinical study to compare the efficacy and safety of DOTSHOT in the treatment of Hangover of AlcoholCTRI/2017/09/009831K Patel phyto Extraction Pvt Ltd30
进行中（未招募）
1 期
Study designed to investigate and confirm that pregabalin is effective in treating neuropathic pain resulting from peripheral nerve trauma.Chronic post-traumatic peripheral neuropathic painMedDRA version: 14.1Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 100000004852EUCTR2012-003304-12-BEPfizer Inc, 235 East 42nd Street, New York, NY 10017539
进行中（未招募）
1 期
Study designed to investigate and confirm that pregabalin is effective in treating neuropathic pain resulting from peripheral nerve trauma.Chronic post-traumatic peripheral neuropathic painMedDRA version: 18.0Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 100000004852EUCTR2012-003304-12-DEPfizer Inc, 235 East 42nd Street, New York, NY 10017700